Early-stage study validates Cellect Bio’s method of stem cell selection; shares ahead 19% – Seeking Alpha
Is stories |
Early-stage study validates Cellect Bio's method of stem cell selection; shares ahead 19%
Seeking Alpha Thinly traded nano cap Cellect Biotechnology Ltd. (APOP +19.4%) jumps on more than a 4x surge in volume in response to its announcement of positive results from a Phase 1 study aimed at validating its proprietary method of stem cell selection called … Cellect Announces Positive Clinical Trial Results |
